JW Pharmaceutical (XKRX:001060) Change In Other Working Capital : ₩-37,749 Mil (TTM As of Sep. 2024)

View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Change In Other Working Capital?

JW Pharmaceutical's Change In Other Working Capital for the quarter that ended in Sep. 2024 was ₩-38,174 Mil. It means JW Pharmaceutical's Other Working Capital declined by ₩38,174 Mil from Jun. 2024 to Sep. 2024 .

JW Pharmaceutical's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was ₩-23,360 Mil. It means JW Pharmaceutical's Other Working Capital declined by ₩23,360 Mil from Dec. 2022 to Dec. 2023 .

JW Pharmaceutical Change In Other Working Capital Historical Data

The historical data trend for JW Pharmaceutical's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Change In Other Working Capital Chart

JW Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Other Working Capital

Get a 7-Day Free Trial

4,408.95

-2,170.18

-2,794.35

13,231.53

-23,359.56

JW Pharmaceutical Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Other Working Capital	Get a 7-Day Free Trial															17,914.40	-18,101.72	3,754.71	14,772.08	-38,173.61

JW Pharmaceutical Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-37,749 Mil.

JW Pharmaceutical Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

JW Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Change In Other Working Capital

Traded in Other Exchanges

001067:Korea 001065.PFD:Korea

Address

2477, Nambusunhwan-ro, Seocho-gu, KOR

Website

https://www.jw-pharma.co.kr

JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical Headlines

No Headlines